Approaches for experimental evaluation of chelating agents

Radiation Protection Dosimetry

Volumn 87, Issue 1, 2000, Pages 19-27

  Stradling, G N ^a   Henge Napoli M H ^b   Paquet, F ^b   Poncy, J L ^c   Fritsch, P ^c   Taylor, D M ^d  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^c CEA DIF   (France)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMERICIUM; CESIUM; CHELATING AGENT; EDETIC ACID; NEPTUNIUM; PENTETIC ACID; PLUTONIUM; RADIOISOTOPE; THORIUM; URANIUM;

ARTICLE; CHELATION THERAPY; DUST; EXPERIMENTAL ANIMAL; FECES; HUMAN; INHALATION; NONHUMAN; RADIATION DOSE; RADIATION EXPOSURE; RADIATION PROTECTION; RADIOACTIVE CONTAMINATION; RADIOISOTOPE DECAY; RADIOISOTOPE DISTRIBUTION; URINE; WOUND;

EID: 0343114386     PISSN: 01448420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.rpd.a032976     Document Type: Article

References (113)

1. Bhattacharyya, M. H., Breitenstein, B. D., Metivier, H., Muggenburg, B. A., Stradling, G. N. and Volf, V. Guidebook for the Treatment of Accidental Internal Contamination of Workers. Eds G. B. Gerber and R. G. Thomas. Radiat. Prot. Dosim. 41(1) (1992).
2. Volf, V. Treatment of Incorporated Transuranium Elements. Technical Report Series No 184 (Vienna: IAEA) (1978).
3. National Council on Radiation Protection and Measurements. Management of Persons Accidentally Contaminated with Radionuclides. Report 65 (Bethesda, MD: NCRP Publications) (1980).
4. World Health Organisation. International Centre in Radiopathology. Radiation Accidents: Management of Overexposure. Collection No 84-03 (Geneva: WHO) (1984).
5. International Atomic Energy Agency. Medical Handling of Accidentally Exposed Individuals. Safety Series No 88 (Vienna: IAEA) (1988).
6. Mettler, F. A., Kelsey, C. A. and Ricks, R. C. Medical Management of Radiation Accidents (Boca Raton, Florida: CRC Press) (1990).
7. International Atomic Energy Agency. Assessment and Treatment of External and Internal Radionuclide Contamination. Technical Document No 869 (Vienna: IAEA) (1996).
8. Norwood, W. D. Treatment of Plutonium Deposition in Humans with DTPA - Effectiveness of Long-term Administration and Oral Administration. In: Proc. 13th Int. Cong. on Occupational Health (New York: United Nations) pp. 335-338 (1960).
9. Lagerquist, C. R., Putzier, E. A. and Piltingsgrud, C. W. Bioassay and Body Counter Results for the First Two Years Following an Acute Plutonium Exposure. Health Phys. 13, 965-972 (1967).
10. Spoor, N. L. The Use of EDTA and DTPA for Accelerating the Removal of Deposited Transuranic Elements from Humans (Chilton: NRPB) NRPB-R-67 (1977).
11. Breitenstein, B. D. and Palmer, H. E. Lifetime Follow-up of the 1976 Americium Accident Victim. Radiat. Prot. Dosim. 26, 317-322 (1989).
12. Schofield, G. B., Howells, H., Ward, F. A., Lynn, J. C. and Dolphin, G. W. Assessment and Management of a Plutonium Contaminated Wound Case. Health Phys. 26, 541-554 (1974).
13. Carbaugh, E. H., Decker, W. A. and Swint, M. J. Medical and Health Physics Management of a Plutonium Wound. Radiat. Prot. Dosim. 26, 345-349 (1989).
14. Wood, R., Britcher, A. R. and McGinn, J. The Effectiveness of DTPA Experience at Sellafield. In: Proc. Regional Conf. of International Radiation Protection Association, Portsmouth, UK (Ashford: Nuclear Technology Publishing) pp. 165-168 (1994).
15. Raymond, K. N. and Smith, W. L. Actinide-sequestering Agents and Decontamination Applications. Struct Bonding 43, 159-185 (1981).
16. Raymond, K. N., Muller, G. and Matzanke, B. F. Complexation of Iron by Siderophores: a Review of their Solution and Structural Chemistry and Biological Function. In: Topics in Current Chemistry 123, 49-102 (1984).
17. 238Pu Elimination from Mice by Poly(catechoylamide) Ligands. Radiat. Res. 99, 85-105 (1984).
18. Lloyd, R. D. and 12 others. Removal of Pu and Am from Beagles and Mice by 3,4,3-LICAM(C) or 3,4,3LICAM(S). Radiat. Res. 99, 106-128 (1984).
19. 3-DTPA of the Dissociation in vitro of the Pu-transferrin Complex Formed after Intravenous Injection of Pu-tri-N-butyl-phosphate. Health Phys. 49, 1302-1305 (1985).
20. Mays, C. W., Lloyd, R. D., Jones, C. W., Bruenger, F. W., Taylor, G. N., Durbin, P. W., White, D. L. and Raymond, K. N. Decorporation of Pu and Am from Beagles with Delayed Daily Injections of 3,4,3-LICAM(C) or Zn-DTPA. Health Phys. 50, 530-534 (1986).
21. Volf, V. Chelation Therapy of Incorporated Plutonium-238 and Americium-241: Comparison of LICAM(C), DTPA and DFOA in Rats, Hamsters, and Mice. Int. J. Radiat. Biol. 49, 449-462 (1986).
22. Volf, V., Taylor, D. M., Brandau, W. and Schlenker, P. The Effect of Pure LICAM(C) on the Retention of Plutoniun-238 in Mice and Rats. Int. J. Radiat. Biol. 50, 204-211 (1986).
23. Duffield, J. R., Taylor, D. M. and Proctor, S. A. The Binding of Plutonium to Transferrin in the Presence of Tri-n-butyl Phosphate or Nitrate and its Release by Diethylenetriaminepenta-acetate and the Tetrameric Catechoylamide Ligand LICAM(C). Int. J. Nucl. Med. Biol. 12, 483-487 (1986).
24. Gerasimo, P., Duserre, C. and Metivier, H. Biological Behavior of Pu Administered to Animals as Pu-standard LICAM(C) Complex: Therapeutical Attempts to Decrease Pu Kidney Burden. Human Toxicol. 5, 309-318 (1986).
25. Stradling, G. N., Slather, J. W., Gray, S. A., Moody, J. C., Ellender, M., Hodgson, A., Volf, V., Taylor, D. M., Wirth, P. and Gaskin, P. W. The Efficacies of Pure LICAM(C) and DTPA on the Retention of Plutonium-238 and Americium-241 in Rats after their Inhalation as Nitrate and Intravenous Injection as Citrate. Int. J. Radiat. Biol. 56, 503-514 (1989).
26. 238Pu(IV) in vivo by 3,4,3-LICAM(C): Effects of Ligand Methylation and pH. Health Phys. 56, 839-855 (1989).
27. Fritsch, P., Lepage, M., Gerasimo, P., Duserre, V. and Metivier, H. Histopathology of Kidney Induced by LICAM(C) Therapy in Baboons after Inhalation of Plutonium-tributyl Phosphate Complex. Radiat. Prot. Dosim. 26, 365-368 (1989).
28. Stradling, G. N., Stather, J. W., Gray, S. A., Moody, J. C., Ellender, M. and Hodgson, A. Efficacies of LICAM(C) and DTPA for the Decorporation of Inhaled Transportable Forms of Plutonium and Americium in the Rat. Human Toxicol. 5, 77-84 (1986).
29. 238Pu(IV) from Mice by Polycatecholate, -hydroxamate or -hydroxypyridinonate Ligands. Radiat. Prot. Dosim. 26, 351-358 (1989).
30. Turowski, P. N., Rodgers, S. J., Scarrow, R. C. and Raymond, K. N. Two Dihydroxamic Acid Derivatives of EDTA and DTPA. Inorg. Chem. 27, 474-481 (1988).
31. White, D. L., Durbin, P. W., Jeung, N. and Raymond, K. N. Specific Sequestering Agents for the Actinides, 16, Synthesis and Initial Biological Testing of Polydentate Oxohydroxy-pyridine Carboxylate Ligands. J. Med. Chem. 31, 11-18 (1998).
32. Fritsch, P., Herbreteau, D., Moutairou, K., Lantenois, G., Richard-Le Naour, H., Grillon, G., Hoffschir, D., Poncy, J. L., Laurent, A. and Masse, R. Comparative Toxicity of 3,4,3LIHOPO and DTPA in Baboons. Radiat. Prot. Dosim. 53, 315-318 (1994).
33. Stradling, G. N., Gray, S. A., Moody, J. C., Hodgson, A., Raymond, K. N., Durbin, P. W., Rodgers, S. J., White, D. L. and Turowski, P. N. The Efficacy of DFO-HOPO, DTPA-DX, and DTPA for Enhancing the Excretion of Plutonium and Americium from the Rat. Int. J. Radiat. Biol. 59, 1269-1277 (1991).
34. Volf, V., Burgada, R., Raymond, K. N. and Durbin, P. W. Early Chelation Therapy for Injected Pu-238 and Am-241 in the Rat: Comparison of 3,4,3-LIHOPO, DFO-HOPO, DTPA-DX, DTPA and DFOA. Int. J. Radiat. Biol. 63, 785-793 (1993).
35. Stradling, G. N. and 12 others. The Efficacies of 3,4,3-LIHOPO and DTPA for Enhancing the Excretion of Plutonium and Americium from the Rat: Comparison with other Siderophore Analogues. Int. J. Radiat. Biol. 62, 487-497 (1992).
36. 238Pu in Rat after Inhalation of the Tributylphosphate Complex. Int. J. Radiat. Biol. 64, 431-436 (1993).
37. 238Pu Inhaled as the Tributylphosphate Complex in Rats Treated by 3,4,3-LIHOPO. Radiat. Prot. Dosim. 53, 323-326 (1994).
38. Stradling, G. N. Recent Progress in Decorporation of Plutonium, Americium, and Thorium. Radiat. Prot. Dosim. 53, 297-304 (1994).
39. Stradling, G. N., Gray, S. A., Moody, J. C., Pearce, M. J., Wilson, I., Burgada, R., Bailly, T., Leroux, Y., Raymond, K. N. and Durbin, P. W. Comparative Efficacies of 3,4,3-LIHOPO and DTPA for Enhancing the Excretion of Plutonium and Americium from the Rat after Simulated Would Contamination. Int. J. Radiat. Biol. 64, 133-140 (1993).
40. Gray, S. A., Stradling, G. N., Pearce, M. J., Wilson, I., Burgada, R., Durbin, P. W. and Raymond, K. N. Removal of Plutonium and Americium from the Rat using 3,4,3-LIHOPO and DTPA: Effect of Delayed Administration and Mass of Plutonium. Radiat. Prot. Dosim. 53, 319-322 (1994).
41. Volf, V., Burgada, R., Raymond, K. N. and Durbin, P. W. Treatment with 3,4,3-LIHOPO of Simulated Wounds Contaminated with Plutonium and Americium in the Rat. Int. J. Radiat. Biol. 70, 109-114 (1996).
42. Paquet, F., Poncy, J. L., Metivier, H., Grillon, G., Fritsch, P., Burgada, R., Bailly, T., Raymond, K. N. and Durbin, P. W. Efficacy of 3,4,3-LI(1,2,-HOPO) for Enhancing the Excretion of Plutonium from Rat after Simulated Wound Contamination as a Tributyl-n-phosphate Complex. Int. J. Radiat. Biol. 68, 663-668 (1995).
43. Volf, V., Burgada, R., Raymond, K. N. and Durbin, P. W. Chelation Therapy by DFO-HOPO and 3,4,3-LIHOPO for Injected Pu-238 and Am-241 in the Rat: Effect of Dosage, Time and Mode of Chelate Administration. Int. J. Radiat. Biol. 70, 765-772 (1996).
44. Durbin, P. W., Kullgren, B., Xu, J. and Raymond, K. N. Development of Decorporation Agents for the Actinides. Radiat. Prot. Dosim. 79(1-4), 433-443 (1998).
45. Durbin, P. W., Kullgren, B., Xu, J. and Raymond, K. N. In vivo chelation of Am(III), Pu(IV), Np(V) and U(VI) in Mice by TREN-(Me-3,2-HOPO). Radiat. Prot. Dosim. 53, 305-309 (1994).
46. Stradling, G. N., Gray, S. A., Pearce, M. J., Wilson, I., Moody, J. C., Hodgson, A. and Raymond, K. N. Efficacy of TREN-(Me-3,2-HOPO). 5-LI(Me-3.2-HOPO) and DTPA for Removing Plutonium and Americium from the Rat after Inhalation and Wound Contamination as Nitrates: Comparison with 3.4.3-LI(1.2.-HOPO) (Chilton: NRPB) M534 (1995).
47. Stradling, N., Hodgson, S. A. and Pearce, M. J. Recent Developments in the Decorporation of Plutonium, Americium and Thorium. Radiat. Prot. Dosim. 79(1-4), 445-448 (1998).
48. Stradling, G. N. Decorporation of Actinides: a Review of Recent Research. J. Alloys Compd. 271-273, 72-77 (1998).
49. Uhlir, L. C., Durbin, P. W., Jeung, N. and Raymond, K. N. Synthesis and Initial Biological Testing of Octadentate Mixed Catecholate-Hydroxypyridinonate Ligands. J. Med. Chem. 36, 504-509 (1993).
50. Xu, J., Durbin, P. W., Kullgren, B. and Raymond, K. N. Synthesis and Initial Biological Evaluation of Multidentate 4-carbamoyl-3-hydroxy-1-methyl-2(1H)-pyridinone Ligands for in vivo Plutonium(IV) Chelation. J. Med. Chem. 38, 2606-2614 (1995).
51. Durbin, P. W., Kullgren, B., Jeung, N., Xu, J., Rodgers, S. J. and Raymond, K. N. Octadentate Catecholamide Ligands for Pu(IV) based on Linear or Preorganized Molecular Backbones. Hum. Exp. Toxicol. 15, 352-360 (1996).
52. Stradling, G. N., Moody, J. C., Gray, S., Ellender, M. and Hodgson, A. The Efficacy of DTPA Treatment after Deposition of Thorium Nitrate in the Rat Lung. Hum. Exp. Toxicol. 10, 15-20 (1991).
53. 234Th from the Rat. Health Phys. 49, 395-403 (1985).
54. Peter-Witt, E. and Volf, V. Efficacy of Different DTPA Treatment Schedules for Removal of Th-234 from Simulated Wounds in Rats. Int. J. Radiat. Biol. 45, 45-49 (1994).
55. Rencova, J., Volf, V. and Burgada, R. Chelation Therapy in Rat with Intramuscularly Deposited Thorium-234. In: Metal Ions in Biology and Medicine, Eds. Ph. Collery, J. Corbella, J. L. Domingo, J. C. Etienne and J. M. Llobel, vol. 4, pp. 490-492 (Paris: John Libby Eurotext) (1996).
56. Rencova, J., Volf, V. and Burgada, R. Chelation Therapy of Thorium Deposited in Rat Lung. Radiat. Prot. Dosim. 79(1-4), 459-462 (1998).
57. Stradling, G. N., Gray, S. A., Pearce, M. J., Wilson, I., Moody, J. C., Burgada, R., Durbin, P. W. and Raymond, K. N. Decorporation of Thorium-238 from the Rat by 3,4,3-LIHOPO and DTPA after Simulated Wound Contamination. Hum. Toxicol. 14, 165-169 (1995).
58. Diamond, G. L. Biological Consequences of Exposure to Soluble Forms of Natural Uranium. Radiat. Prot. Dosim. 26(1-4), 26-33 (1989).
59. Leggett, R. W. The Behaviour and Chemical Toxicity of U in the Kidney: a Reassessment. Health Phys. 57(3), 365-383 (1989).
60. Basinger, M. A. and Jones, M. M. Tiron (sodium 4,5-dihydroxybenzene-1,3-disulphonate) as an Antidote for Acute Uranium Intoxication in Mice. Res. Commun. Chem. Pathol. Pharmacol. 34, 351-358 (1981).
61. Basinger, M. A., Forti, R. L. and Burka, L. T. Phenolic Chelating Agents as Antidotes for Acute Uranyl Acetate in Mice. J. Toxicol. Environ. Health 64, 237-246 (1983).
62. Ortega, H., Domingo, J. L., Gomez, M. and Corbella, J. Treatment of Experimental Acute Uranium Poisoning by Chelating Agents. Pharmacol. Toxicol. 64, 247-251 (1989).
63. Domingo, J. L., Ortega, A., Llobet, J., Paternain, J. L. and Corbella, J. The Effects of Repeated Parenteral Administration of Chelating Agents on the Distribution and Excretion of Uranium. Res. Commun. Path. Pharmacol. 64, 161-164 (1989).
64. Domingo, J. L., Ortega, A., Llobet, J. M. and Corbella, J. Effectiveness of Chelation Therapy with Time after Acute Uranium Intoxication. Fund. Appl. Pharmacol. 14, 88-95 (1990).
65. 2) in Rats. Res. Commun. Chem. Pathol. Pharmacol. 72, 125-128 (1991).
66. Stradling, G. N., Gray, S. A., Moody, J. C. and Ellender, M. The Efficacy of Tiron for Enhancing the Excretion of Uranium from the Rat. Hum. Exp. Toxciol. 10, 195-198 (1991).
67. Bulman, R. The Chemistry of Chelating Agents in Medical Sciences. Struct. Bonding 67, 91-141 (1987).
68. Gillard, R. D., Newman, P. D. and Collins, J. D. Speciation in Aqueous Solutions of Diethylenetriaminepentamethylenephosphonic Acid and some Metal Complexes. Polyhedron 8, 2077-2086 (1989).
69. Ebetino, F. H., Degenhardt, C. R., Jamieson, L. A. and Burdsall, D. C. Recent Work on the Synthesis of Phosphonate-containing Bone Active Heterocycles. Heterocycles 30(2), 855-862 (1990).
70. Ebetino, F. H. and Jamieson, L. A. The Design and Synthesis of Bone-active Phosphinic Acid Analogues. 1. The Pyridylaminomethanephosphonoalkylphosphinates. Phosphorus, Sulfur, Silicon 51/52, 23-26 (1990).
71. Bailly, T., Burgada, R., Stradling, G. N. and Gray, S. A. Synthesis of New Ligands for Uranium Decorporation. EULEP Newsletter 75, 37 (1994).
72. Balabukha, V. S., Ivannikov, A. T. and Razbitnaya, L. I. Polyaminepolyalkylphosphonic Acids as Effective Ligands for Binding and Eliminating Uranium and its Fission Products from the Body. In: Proc. Second IRPA Congress on Radiation Protection, pp. 293-297 (Budapest: Akademiai Kiado) (1973).
73. Seidel, A. Biology of Uranium. In: Gmelin Handbuch der Anorganischen Chemie. Vol. A7, Supplement 1, pp. 300-341 (Berlin: Springer-Verlag) (1982).
74. Gray, S. A., Stradling, G. N., Pearce, M., Moody, J. C. and Ebetino, F. H. Efficacy of some Phosphonic Acid Derivatives for Enhancing the Excretion of Uranium from the Rat. Report NRPB-M-339 (Chilton: National Radiological Protection Board) (1992).
75. Ubios, A. M., Braun, E. M. and Cabrini, R. L. Lethality due to Uranium Poisoning is Prevented by Ethane-1-hydroxy-1,1-bisphosphonate (EHBP). Health Phys. 66, 540-544 (1994).
76. Hengé-Napoli, M.-H., Ansoborlo, E., Houpert, P., Mirto, H., Paquet, F., Burgada, R., Hodgson, S. A. and Stradling, G. N. Progress and Trends in in vivo Chelation of Uranium. Radiat. Prot. Dosim. 79(1-4), 449-452 (1998).
77. Henǵe-Napoli, M.-H., Ansoborlo, E., Chazal, V., Houpert, P., Paquet, F. and Gourmelon, P. Efficacy of Ethane-hydroxy-1, 1-bisphosphonate (EHBP) for the Decorporation of Uranium after Intramuscular Contamination in Rats. Int. J. Radiat. Biol. (in press).
78. Archimbaud, M., Hengé-Napoli, M.-H., Lilienbaum, D., Desloges, M. and Montagne, C. Application of Calixarenes for the Decorporation of Uranium: Present Limitations and Future Trends. Radiat. Prot. Dosim. 53(1-4), 327-330 (1994).
79. Hengé-Napoli, M.-H., Archimbaud, M., Ansoborlo, E., Métivier, H. and Gourmelon, P. Efficacy of 3,4,3-LIHOPO for Reducing the Retention of Uranium in Rat after Acute Administration. Int. J. Radiat. Biol. 68, 389-393 (1995).
80. Durbin, P. W., Kullgren, B., Xu, J. and Raymond, K. N. New Agents for in vivo Chelation of Uranium (VI): Efficacy and Toxicity in Mice of Multidentate Catecholate and Hydroxypyridinonate Ligands. Health Phys. 72: 865-879 (1997).
81. Xu, J., Raymond, K. N., Durbin, P. W. and Kullgren, B. Uranyl Ion Sequestering Agents - Design, Structural and Biological Evaluation. Angewandte Chemie (in press).
82. Xu, J., Raymond, K. N., Kullgren, B. and Durbin, P. W. Tetradentate Hydroxypyridinonate Uranium(VI) Sequestering Agents: Design, Synthesis, Structure, and Efficacy as Uranium Decorporation Agents. J. Am. Chem. Soc. (in press).
83. 239Np. In: Hanford Biology Research Annual Report for 1963, 805000, pp. 73-75 (Richland, WA: Hanford Laboratory) (1964).
84. Smith, V. H. Therapeutic Removal of Internally Deposited Transuranium Elements. Health Phys. 22, 765-778 (1972).
85. 237Np in the Rat. Health Phys. 24, 311-315 (1973).
86. 242Cm in Bone. Health Phys. 22, 657-665 (1972).
87. Nenot, J. C., Lushbaugh, C. C. and Lincoln, T. A. Manual on Early Medical Treatment of Possible Radiation Injury with Appendix on Sodium Burns. Safety Series No 47 (Vienna: IAEA) (1978).
88. Thompson, R. C. Neptunium - The Neglected Actinide: a Review of the Biological and Environmental Literature. Radiat. Res. 90, 1-32 (1982).
89. Volf, V. and Wirth, R. Effective Chelation Therapy after Incorporation of Neptunium-239 in Rats. Int. J. Radiat. Biol. 50, 955-959 (1986).
90. Paquet, F., Métivier, H. and Masse, R. Le Neptunium: pourquoi de Nouvelles Études. Radioprotection 29, 387-396 (1994).
91. Paquet, F., Metivier, H., Poncy, J.-L. and Burgada, R. Evaluation of DTPA and other New Agents for Removing Neptunium from Target Organs. Int. J. Radiat. Biol. 71, 613-621 (1997).
92. 237Neptunium: Oxidation State in vivo and Chelation by Multidentate Catecholate and Hydroxypyridinonate Ligands. Health Phys. 75, 34-50 (1998).
93. Ramounet, B., Matton, S., Grillon, G., Poncy, J.-L. and Fritsch, P. Efficacy of Localised DTPA Treatment for Decorporation of Np Injected Intramuscularly as Np (IV) or Np (V). Radiat. Prot. Dosim. 79(1-4), 463-465 (1998).
94. Wirth, R., Taylor, D. M. and Duffield, J. Identification of Transferrin as the Principal Neptunium-binding Protein in the Blood Serum of Rats. Int. J. Nucl. Med. Biol. 12, 327-330 (1985).
95. Paquet, F., Ramounet, B., Metivier, H. and Taylor, D. M. The Effect of the Mass and Initial Chemical Form of Neptunium on its Molecular Associations in Blood and Liver. Radiat. Res. 146, 306-312 (1996).
96. Paquet, F., Ramounet, B., Hengé-Napoli, M.-H. and Métivier, H. In vitro Experiments to Determine the Mechanisms by which Chelators Remove Neptunium and Uranium from the Body. Radiat. Prot. Dosim. 79(1-4), 467-470 (1998).
97. Duplessis, J., Genet, M. and Guillamont, R. Comportement Redox du Neptunium a l'Échelle des Indicateurs en Milieux Acqueux. Radiochem. Acta 21, 21-28 (1974).
98. Madshus, K., Stromme, A., Bohne, F. and Nigrovic, V. Diminution of Radiocesium Body-burden in Dogs and Human Beings by Prussian Blue. Int. J. Radiat. Biol. 10, 519-520 (1966).
99. 137Cs Metabolism in Humans. In: Assessment of Radioactive Contamination in Man, pp. 499-506 (Vienna: IAEA) (1985).
100. Tang Minh-hua, Gong Yi-fen, Shen Cheng-yao, Ye Chang-quing and Wu De-chang. Measurement of Internal Contamination with Radioactive Caesium Released from Chernobyl Accident and Enhanced Elimination by Prussian Blue. J. Radiol. Prot. 8, 25-28 (1988).
101. Lipszstein, J. L., Bertelli, L., Oliveira, C. A. and Dantas, B. M. Studies of Cs Retention in the Human Body related to Body Parameters and Prussian Blue Administration. Health Phys. 60, 57-61 (1991).
102. 137Cs Decorporation: The Goinnia Radiological Accident. Health Phys. 60, 63-66 (1991).
103. 137Cs Internal Contamination Involving a Brazilian Accident, and the Efficacy of Prussian Blue Treatment. Health Phys. 66, 245-252 (1994).
104. International Atomic Energy Agency. Dosimetric and Medical Aspects of the Radiological Accident in Goiania in 1987. IAEA-TECDOC-1009 (Vienna: IAEA) (1998).
105. 59Fe. Health Phys. 71, 713-718 (1996).
106. 137Cs in Beagles of Different Ages. Health Phys. 71, 190-197 (1996).
107. Neilson, P., Dresow, B., Fischer, R. and Heinrich, H. C. Inhibition of Intestinal Absorption and Decorporation of Radiocaesium in Humans by Hexacyanoferrates. Int. J. Radiat. Appl. Instrum. 18, 821-826 (1991).
108. Dresow, B., Nielson, P. and Heinrich, H. C. Efficacy of Different Hexacyanoferrates in Inhibiting the Intestinal Absorption of Radiocaesium in Rats. Z. Naturforsch. 45, 676-680 (1990).
109. Dresow, B., Nielson, P., Fischer, R., Pfau, A. A. and Heinrich, H. C. In vivo Binding of Radiocaesium by Two Forms of Prussian Blue and by Ammonium Iron Hexacyanoferrate (II). J. Toxicol. Clin. Toxicol. 31, 563-569 (1993).
110. Nigrovic, V. and Catsch, A. Dekorporation von radionukliden. Strahlentherapie 128, 283-287 (1995).
111. Llobert, J. M., Domingo, J. L. and Corbella, J. Comparison of the Effectiveness of Several Chelators after Single Administration on the Toxicity, Excretion and Distribution of Cobalt. Arch. Toxicol. 58, 278-281 (1986).
112. Llobert, J. M., Domingo, J. L. and Corbella, J. Comparative Effects of Repeated Parenteral Administration of Several Chelators on the Distribution and Excretion of Cobalt. Res. Commun. Chem. Pathol. Pharmacol. 60, 225-233 (1988).
113. 144Ce in Pregnant Mice and Foeto-placental Unit. Int. J. Radiat. Biol. 28, 125-136 (1975).